Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
BioNTech SE
Edson D Moreira; Nicholas Kitchin; Xia Xu; Samuel S Dychter; Stephen Lockhart; Alejandra Gurtman; John L Perez; Cristiano Zerbini; Michael E Dever; Timothy W Jennings; Donald M Brandon; Kevin D Cannon; Michael J Koren; Douglas S Denham; Mezgebe Berhe; David Fitz-Patrick; Laura L Hammitt; Nicola P Klein; Haylene Nell; Georgina Keep; Xingbin Wang; Kenneth Koury; Kena A Swanson; David Cooper; Claire Lu; Özlem Türeci; Eleni Lagkadinou; Dina B Tresnan; Philip R Dormitzer; Uğur Şahin; William C Gruber; Kathrin U Jansen; C4591031 Clinical Trial Group